Introduction
Cette page fournit une analyse complète de l'historique des opérations d'initiés connues de Brian P Mckeon. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. Il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations spécifiques et non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leur propre entreprise. Toutefois, ils doivent déclarer toutes les opérations à la SEC au moyen d'un formulaire 4. Malgré ces restrictions, les recherches universitaires indiquent que les initiés, en général, ont tendance à surperformer le marché dans leurs propres entreprises.
Rentabilité moyenne des opérations
La rentabilité moyenne des opérations est le rendement moyen de tous les achats effectués par l'initié sur le marché public au cours des trois dernières années. Pour ce faire, nous examinons tous les achats non planifiés effectués par l'initié sur le marché public, à l'exclusion de toutes les opérations d'initiés effectuées dans le cadre d'un plan de négociation 10b5-1. Nous calculons ensuite la performance moyenne de ces transactions sur 3, 6 et 12 mois, en faisant la moyenne de chacune de ces durées pour générer un indicateur de performance final pour chaque opération. Enfin, nous faisons la moyenne de tous les indicateurs de performance pour calculer un indicateur de performance pour l'initié. Cette liste ne comprend que les initiés ayant effectué au moins trois opérations d'initiés au cours des deux dernières années.
Si la rentabilité des opérations de cet initié est "N/A", cela signifie qu'il n'a pas effectué d'opérations d'achat sur le marché public au cours des trois dernières années, ou que les opérations qu'il a effectuées sont trop récentes pour permettre le calcul d'un indicateur de performance fiable.
Fréquence de mise à jour : Quotidienne
Entreprises ayant déclaré des positions d'initiés
Les dépôts de la SEC indiquent que Brian P Mckeon a déclaré des participations ou des opérations dans les entreprises suivantes :
Titre | Fonction | Dernières positions déclarées |
---|---|---|
US:ALKS / Alkermes plc | Director | 33 869 |
US:IDXX / IDEXX Laboratories, Inc. | EVP, CFO and Treasurer | 31 550 |
US:04685W103 / athenahealth, Inc. | Director | 0 |
US:IRM / Iron Mountain Incorporated | Chief Financial Officer | 10 991 |
Comment interpréter les graphiques
Les graphiques suivants montrent la performance des titres après chaque opération non planifiée effectuée par Brian P Mckeon sur le marché public. Les opérations non planifiées sont des opérations qui n'ont pas été effectuées dans le cadre d'un plan de négociation 10b5-1. La performance des actions est représentée sous la forme d'une variation cumulée en pourcentage du cours de l'action. Par exemple, si une opération d'initié a été effectuée le 1er janvier 2019, le graphique montrera la variation quotidienne en pourcentage du titre jusqu'à aujourd'hui. Si le prix de l'action passait de 10 à 15 dollars pendant cette période, la variation cumulée en pourcentage du prix de l'action serait de 50 %. Une variation du cours de 10 à 20 dollars serait de 100 %, et une variation du cours de 10 à 5 dollars serait de -50 %.
Enfin, nous essayons de déterminer dans quelle mesure les opérations d'un initié sont en corrélation avec les rendements excédentaires (positifs ou négatifs) du cours de l'action, afin de déterminer si l'initié synchronise ses opérations pour tirer profit d'informations d'initié. Imaginons qu'un initié agisse de la sorte. Dans ce cas, nous nous attendrions soit (a) à des rendements positifs après les achats, soit (b) à des rendements négatifs après les ventes. Dans le cas (a), le graphique des ACHAT montrerait une série de courbes ascendantes, indiquant des rendements positifs après chaque transaction d'achat. Dans le cas (b), le graphique VENTE montre une série de courbes inclinées vers le bas, indiquant des rendements négatifs après chaque transaction de vente.
Toutefois, cela ne suffit pas pour tirer des conclusions. Si, par exemple, le cours de l'action de l'entreprise a connu une hausse non cyclique pendant de nombreuses années, nous nous attendrions à ce que tous les graphiques postérieurs à l'achat soient en pente ascendante. De même, des baisses non cycliques sur de nombreuses années se traduiraient par des graphiques post-achat en pente descendante. Aucun de ces graphiques ne suggère l'existence d'opérations d'initiés.
L'indicateur le plus fort serait une situation dans laquelle le prix de l'action serait extrêmement cyclique et où il y aurait à la fois des signaux positifs dans le graphique ACHAT et des courbes négatives dans le graphique VENTE. Cette situation suggère fortement la présence d'un initié qui planifie les opérations d'initiés de manière à en tirer un avantage financier.
Achats d'initiés ALKS / Alkermes plc - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans ALKS / Alkermes plc. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les achats les plus récents sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Max |
Prix à Max |
Bénéfice Max ($) |
Rendement maximal (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2021-08-02 | ALKS | MCKEON BRIAN P | 10 000 | 26,4269 | 10 000 | 26,4269 | 264 269 | 57 | 32.13 | 57 031 | 21,58 |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Ventes d'initiés ALKS / Alkermes plc - Analyse des pertes à court terme
Dans cette section, nous analysons la capacité à éviter les pertes à court terme lors de chaque vente d'initié non planifiée et réalisée sur le marché public dans ALKS / Alkermes plc. Un modèle régulier d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur un an après chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les dernières opérations sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Min |
Prix à Min |
Perte maximale évitée ($) |
Perte maximale évitée (%) |
---|---|---|---|---|---|---|---|
Il n'y a pas d'opérations d'initiés non planifiées connues sur le marché public pour cette combinaison d'initiés et de titres. |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Historique des opérations d'initiés
Ce tableau présente la liste complète des opérations d'initiés effectuées par Brian P Mckeon, telles que divulguées à la Securities Exchange Commission (SEC).
Date de dépôt | Date de l'opération | Formulaire | Libellé | Titre | Code | Actions | Actions restantes | Pourcentage de variation |
Prix de l'action |
Valeur de l'opération |
Valeur restante |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -1 924 | 33 869 | -5,38 | 30,61 | -58 894 | 1 036 730 | |
2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 013 | 35 793 | 28,84 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -569 | 31 550 | -1,77 | 444,53 | -252 938 | 14 024 740 | |
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 299 | 32 119 | 0,94 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 820 | 0,98 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 512 | 0,97 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 252 | 31 209 | 0,81 | ||||
2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -117 | 30 932 | -0,38 | 455,08 | -53 244 | 14 076 349 | |
2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 31 049 | 0,62 | ||||
2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -1 465 | 27 780 | -5,01 | 24,10 | -35 306 | 669 498 | |
2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 6 104 | 29 245 | 26,38 | ||||
2024-02-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 483 | 30 835 | 1,59 | 206,94 | 99 952 | 6 380 911 | |
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 097 | 30 352 | -3,49 | 560,56 | -614 934 | 17 013 889 | |
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 449 | 0,99 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 141 | 0,98 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 30 838 | 0,83 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 432 | 30 585 | 1,43 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 30 153 | 1,46 | ||||
2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -1 088 | 23 141 | -4,49 | 27,32 | -29 724 | 632 212 | |
2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 533 | 24 229 | 23,01 | ||||
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -681 | 29 718 | -2,24 | 572,80 | -390 080 | 17 022 359 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -7 128 | 30 399 | -18,99 | 571,84 | -4 076 062 | 17 383 073 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -5 675 | 37 527 | -13,14 | 570,97 | -3 240 253 | 21 426 547 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 912 | 43 202 | -8,30 | 569,91 | -2 229 500 | 24 621 158 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 469 | 47 114 | -3,02 | 568,84 | -835 633 | 26 800 327 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 564 | 48 583 | -3,12 | 567,35 | -887 333 | 27 563 271 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -701 | 50 147 | -1,38 | 566,53 | -397 140 | 28 409 700 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 581 | 50 848 | -3,02 | 564,98 | -893 227 | 28 727 669 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -615 | 52 429 | -1,16 | 563,82 | -346 747 | 29 560 069 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 23 326 | 53 044 | 78,49 | 141,60 | 3 302 962 | 7 510 973 | |
2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -117 | 29 692 | -0,39 | 504,08 | -58 977 | 14 967 318 | |
2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 29 809 | 0,65 | ||||
2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -1 430 | 19 696 | -6,77 | 29,88 | -42 728 | 588 516 | |
2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 5 957 | 21 126 | 39,27 | ||||
2023-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 560 | 29 605 | 1,93 | 178,26 | 99 826 | 5 277 449 | |
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 208 | 29 031 | -3,99 | 503,65 | -608 409 | 14 621 283 | |
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 30 239 | 1,01 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 29 936 | 0,85 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 29 683 | 1,48 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 29 250 | 1,51 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 504 | 28 815 | 1,78 | ||||
2023-02-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 445 | 15 169 | 41,45 | ||||
2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -90 | 28 276 | -0,32 | 407,78 | -36 700 | 11 530 242 | |
2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 28 366 | 0,68 | ||||
2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -795 | 10 724 | -6,90 | 27,19 | -21 616 | 291 586 | |
2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 7 585 | 11 519 | 192,81 | ||||
2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -706 | 0 | -100,00 | ||||
2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 706 | 28 154 | 2,57 | 141,60 | 99 970 | 3 986 556 | |
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -253 | 4 785 | -5,02 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -433 | 5 038 | -7,91 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -435 | 5 471 | -7,37 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -505 | 5 906 | -7,88 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -459 | 6 411 | -6,68 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 212 | 6 870 | 21,42 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 197 | 197 | |||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 502 | 10 502 | |||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -964 | 27 448 | -3,39 | 505,53 | -487 331 | 13 875 607 | |
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 28 412 | 0,90 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 28 159 | 1,56 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 27 726 | 1,59 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 27 291 | 1,89 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 26 786 | 1,74 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | -4 446 | 8 890 | -33,34 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | -2 223 | 0 | -100,00 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -1 823 | 3 934 | -31,67 | 23,55 | -42 932 | 92 646 | |
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 446 | 5 757 | 339,13 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | -912 | 1 311 | -41,03 | 23,55 | -21 478 | 30 874 | |
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 2 223 | 2 223 | |||||
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -9 225 | 0 | -100,00 | ||||
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 273 | 26 317 | -7,95 | 621,26 | -1 412 126 | 16 349 501 | |
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -6 952 | 28 590 | -19,56 | 620,55 | -4 314 062 | 17 741 297 | |
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 225 | 35 542 | 35,05 | 67,85 | 625 916 | 2 411 500 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -20 000 | 9 225 | -68,43 | ||||
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -872 | 26 317 | -3,21 | 629,80 | -549 186 | 16 574 232 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 375 | 27 189 | -4,81 | 628,78 | -864 574 | 17 095 707 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 974 | 28 564 | -9,43 | 627,97 | -1 867 572 | 17 937 008 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 813 | 31 538 | -5,44 | 626,74 | -1 136 282 | 19 765 937 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 326 | 33 351 | -6,52 | 625,46 | -1 454 831 | 20 859 650 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 142 | 35 677 | -5,66 | 624,53 | -1 337 747 | 22 281 198 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 493 | 37 819 | -3,80 | 623,34 | -930 649 | 23 573 933 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -5 743 | 39 312 | -12,75 | 622,36 | -3 574 235 | 24 466 139 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 262 | 45 055 | -2,72 | 621,40 | -784 203 | 27 996 820 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 20 000 | 46 317 | 76,00 | 67,85 | 1 357 000 | 3 142 584 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -6 310 | 29 225 | -17,76 | ||||
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -607 | 26 317 | -2,25 | 631,01 | -383 024 | 16 606 086 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -5 703 | 26 924 | -17,48 | 630,13 | -3 593 652 | 16 965 495 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 310 | 32 627 | 23,98 | 67,85 | 428 134 | 2 213 718 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -10 000 | 35 535 | -21,96 | ||||
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -110 | 26 317 | -0,42 | 632,19 | -69 541 | 16 637 176 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -743 | 26 427 | -2,73 | 631,39 | -469 122 | 16 685 478 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -971 | 27 170 | -3,45 | 630,39 | -612 112 | 17 127 572 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 094 | 28 141 | -6,93 | 629,63 | -1 318 446 | 17 718 207 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 356 | 30 235 | -7,23 | 628,19 | -1 480 024 | 18 993 206 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 326 | 32 591 | -3,91 | 627,41 | -831 942 | 20 447 594 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 100 | 33 917 | -3,14 | 626,47 | -689 122 | 21 247 918 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 300 | 35 017 | -3,58 | 625,25 | -812 824 | 21 894 131 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 10 000 | 36 317 | 38,00 | 67,85 | 678 500 | 2 464 084 | |
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -192 | 5 658 | -3,28 | ||||
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -96 | 26 308 | -0,36 | 705,76 | -67 753 | 18 566 882 | |
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 26 404 | 0,73 | ||||
2021-08-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
P - Purchase | 10 000 | 10 000 | 26,43 | 264 269 | 264 269 | ||
2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 7 585 | 7 585 | |||||
2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 15 677 | 15 677 | |||||
2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 474 | 0 | -100,00 | ||||
2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 474 | 26 188 | 5,96 | 67,85 | 100 011 | 1 776 856 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 307 | 24 714 | -5,02 | 539,58 | -705 231 | 13 335 180 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -433 | 5 850 | -6,89 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -435 | 6 283 | -6,48 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -505 | 6 718 | -6,99 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -459 | 7 223 | -5,98 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -810 | 7 682 | -9,54 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 011 | 8 492 | 13,51 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 183 | 183 | |||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 9 538 | 9 538 | |||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 335 | 26 021 | -4,88 | 544,08 | -726 347 | 14 157 506 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 27 356 | 1,61 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 26 923 | 1,64 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 26 488 | 1,94 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 25 983 | 1,80 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 25 524 | 3,28 | ||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 2 223 | 2 223 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 4 549 | 4 549 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 13 336 | 13 336 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 26 169 | 26 169 | |||||
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 000 | 18 050 | -14,25 | 478,13 | -1 434 380 | 8 630 189 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 100 | 21 050 | -9,07 | 476,89 | -1 001 466 | 10 038 503 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -300 | 23 150 | -1,28 | 475,50 | -142 650 | 11 007 825 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 338 | 23 450 | -12,46 | 475,02 | -1 585 625 | 11 139 278 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 241 | 26 788 | -4,43 | 474,14 | -588 404 | 12 701 177 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -21 | 28 029 | -0,07 | 472,88 | -9 931 | 13 254 418 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -36 216 | 0 | -100,00 | ||||
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -200 | 24 700 | -0,80 | 481,26 | -96 252 | 11 887 122 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -566 | 24 900 | -2,22 | 480,31 | -271 854 | 11 959 639 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 534 | 25 466 | -5,68 | 479,69 | -735 851 | 12 215 900 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -390 | 27 000 | -1,42 | 477,02 | -186 036 | 12 879 446 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 596 | 27 390 | -11,61 | 476,01 | -1 711 740 | 13 037 974 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 474 | 30 986 | -10,08 | 475,20 | -1 650 846 | 14 724 560 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -244 | 34 460 | -0,70 | 473,97 | -115 648 | 16 332 934 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 407 | 34 704 | -6,49 | 473,04 | -1 138 602 | 16 416 300 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 107 | 37 111 | -2,90 | 472,20 | -522 721 | 17 523 666 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 493 | 38 218 | -6,12 | 471,02 | -1 174 259 | 18 001 534 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -2 850 | 40 711 | -6,54 | 469,80 | -1 338 921 | 19 125 898 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -9 617 | 43 561 | -18,08 | 469,09 | -4 511 281 | 20 434 221 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -6 338 | 53 178 | -10,65 | 467,97 | -2 965 970 | 24 885 507 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -1 400 | 59 516 | -2,30 | 467,01 | -653 820 | 27 794 817 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 36 216 | 60 916 | 146,62 | 79,54 | 2 880 621 | 4 845 259 | |
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 256 | 0 | -100,00 | ||||
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 880 | 0 | -100,00 | ||||
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 256 | 52 732 | 2,44 | 79,54 | 99 902 | 4 194 303 | |
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 51 486 | 3,79 | 53,18 | 99 988 | 2 738 283 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -37 098 | 0 | -100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -37 836 | 0 | -100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -8 790 | 0 | -100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -3 049 | 49 596 | -5,79 | 381,48 | -1 163 118 | 18 919 654 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -14 469 | 52 645 | -21,56 | 380,12 | -5 499 962 | 20 011 438 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -37 209 | 67 114 | -35,67 | 379,20 | -14 109 701 | 25 449 716 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -28 997 | 104 323 | -21,75 | 377,84 | -10 956 290 | 39 417 632 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 098 | 133 320 | 38,55 | 62,00 | 2 300 076 | 8 265 840 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 836 | 96 222 | 64,80 | 53,18 | 2 012 308 | 5 117 567 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 8 790 | 58 386 | 17,72 | 43,68 | 383 947 | 2 550 300 | |
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -193 | 7 481 | -2,51 | ||||
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -97 | 49 596 | -0,20 | 395,71 | -38 384 | 19 625 633 | |
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 193 | 49 693 | 0,39 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -435 | 7 674 | -5,36 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -505 | 8 109 | -5,86 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -459 | 8 614 | -5,06 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -810 | 9 073 | -8,20 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -628 | 9 883 | -5,97 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 731 | 10 511 | 19,72 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 17 813 | 17 813 | |||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -979 | 49 457 | -1,94 | 288,78 | -282 716 | 14 282 192 | |
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 50 436 | 0,87 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 50 001 | 1,02 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 49 496 | 0,94 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 49 037 | 1,68 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 628 | 48 227 | 1,32 | ||||
2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 961 | 8 780 | 12,29 | ||||
2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 058 | 0 | -100,00 | ||||
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -7 504 | 0 | -100,00 | ||||
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -629 | 47 528 | -1,31 | 248,79 | -156 492 | 11 824 695 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -5 771 | 48 157 | -10,70 | 248,28 | -1 432 819 | 11 956 377 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -225 | 53 928 | -0,42 | 247,28 | -55 638 | 13 335 375 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -375 | 54 153 | -0,69 | 245,77 | -92 165 | 13 309 324 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -300 | 54 528 | -0,55 | 244,57 | -73 372 | 13 336 093 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -204 | 54 828 | -0,37 | 242,72 | -49 514 | 13 307 611 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 7 504 | 55 032 | 15,79 | 44,04 | 330 514 | 2 423 884 | |
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -505 | 7 819 | -6,07 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -459 | 8 324 | -5,23 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -811 | 8 783 | -8,45 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -629 | 9 594 | -6,15 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -726 | 10 223 | -6,63 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | 2 175 | 10 949 | 24,79 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | 483 | 483 | |||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | 20 753 | 20 753 | |||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 612 | 47 496 | -3,28 | 206,94 | -333 587 | 9 828 822 | |
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 49 108 | 1,04 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 48 603 | 0,95 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 48 144 | 1,71 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 47 333 | 1,35 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 46 704 | 1,58 | ||||
2019-02-13 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
D - Sale to Issuer | -2 721 | 0 | -100,00 | 135,00 | -367 335 | ||
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -2 820 | 8 774 | -24,32 | ||||
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 006 | 45 978 | -2,14 | 186,02 | -187 136 | 8 552 828 | |
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 48 984 | 6,11 | ||||
2018-06-08 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 1 931 | 2 721 | 244,43 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -459 | 11 594 | -3,81 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -811 | 12 053 | -6,30 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -629 | 12 864 | -4,66 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -726 | 13 493 | -5,11 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 524 | 14 219 | 21,58 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 560 | 560 | |||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 25 140 | 25 140 | |||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -903 | 44 040 | -2,01 | 178,26 | -160 969 | 7 850 570 | |
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 44 943 | 1,03 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 44 484 | 1,86 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 43 673 | 1,46 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 43 044 | 1,72 | ||||
2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 880 | 1 880 | -50,00 | ||||
2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 42 318 | 4,65 | 53,18 | 99 988 | 2 250 683 | |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -6 602 | 0 | -100,00 | ||||
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -1 200 | 40 438 | -2,88 | 182,33 | -218 792 | 7 372 923 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -3 706 | 41 638 | -8,17 | 181,44 | -672 406 | 7 554 678 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -1 696 | 45 344 | -3,61 | 180,53 | -306 171 | 8 185 735 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 602 | 47 040 | 16,33 | 38,80 | 256 125 | 1 824 917 | |
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -2 820 | 11 695 | -19,43 | ||||
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 095 | 40 438 | -2,64 | 156,38 | -171 236 | 6 323 694 | |
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 41 533 | 7,28 | ||||
2017-09-06 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 790 | 790 | |||||
2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 880 | 3 760 | -33,33 | ||||
2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 38 548 | 5,13 | 53,18 | 99 988 | 2 050 175 | |
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -811 | 14 515 | -5,29 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -629 | 15 326 | -3,94 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -726 | 15 955 | -4,35 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 295 | 16 681 | 15,95 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 706 | 706 | |||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 23 326 | 23 326 | |||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -809 | 36 668 | -2,16 | 141,60 | -114 554 | 5 192 189 | |
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 37 477 | 2,21 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 36 666 | 1,75 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 36 037 | 2,06 | ||||
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | -9 924 | 0 | -100,00 | ||||
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -970 | 35 311 | -2,67 | 142,24 | -137 971 | 5 022 573 |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -8 954 | 36 281 | -19,79 | 141,57 | -1 267 620 | 5 136 308 |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 924 | 45 235 | 28,10 | 26,66 | 264 524 | 1 205 739 | |
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -2 820 | 14 386 | -16,39 | ||||
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 105 | 35 311 | -3,03 | 117,27 | -129 583 | 4 140 921 | |
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 36 416 | 8,39 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -629 | 17 206 | -3,53 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -726 | 17 835 | -3,91 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 45 535 | 45 535 | |||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -505 | 33 331 | -1,49 | 67,85 | -34 264 | 2 261 508 | |
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -629 | 17 206 | -3,53 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -726 | 17 835 | -3,91 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 35 535 | 45 535 | 355,35 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -505 | 33 331 | -1,49 | 67,85 | -34 264 | 2 261 508 | |
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | -9 054 | 0 | -100,00 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -4 854 | 32 461 | -13,01 | 70,06 | -340 080 | 2 274 279 |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -4 200 | 37 315 | -10,12 | 69,17 | -290 507 | 2 581 015 |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 054 | 41 515 | 27,89 | 17,18 | 155 593 | 713 435 | |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | -1 880 | 5 640 | -25,00 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 32 461 | 6,15 | 53,18 | 99 988 | 1 726 438 | |
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -2 820 | 14 508 | -16,27 | ||||
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -1 129 | 30 581 | -3,56 | 72,92 | -82 327 | 2 229 967 | |
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 31 710 | 9,76 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -3 000 | 14 445 | -17,20 | 157,36 | -472 088 | 2 273 104 |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -2 000 | 17 445 | -10,29 | 156,44 | -312 873 | 2 729 036 |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 5 000 | 19 445 | 34,61 | 29,27 | 146 350 | 569 155 | |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -363 | 8 664 | -4,02 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 572 | 9 027 | 21,09 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 628 | 628 | |||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 108 | 18 108 | |||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -117 | 14 445 | -0,80 | 159,08 | -18 612 | 2 297 911 | |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 363 | 14 562 | 2,56 | ||||
2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
M - Exercise | -940 | 3 760 | -20,00 | ||||
2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 940 | 14 199 | 7,09 | 106,37 | 99 988 | 1 510 348 | |
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | -1 411 | 7 455 | -15,91 | ||||
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | -493 | 13 259 | -3,58 | 148,27 | -73 097 | 1 965 912 | |
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 411 | 13 752 | 11,43 | ||||
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | -2 934 | 0 | -100,00 | ||||
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -2 934 | 12 341 | -19,21 | 142,17 | -417 127 | 1 754 520 |
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 934 | 15 275 | 23,77 | 56,95 | 167 091 | 869 911 | |
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | -4 800 | 0 | -100,00 | ||||
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | -4 800 | 12 341 | -28,00 | 126,05 | -605 040 | 1 555 583 |
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 4 800 | 17 141 | 38,89 | 30,50 | 146 376 | 522 715 | |
2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 815 | 8 866 | 25,74 | ||||
2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 549 | 18 549 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 7 051 | 7 051 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 4 700 | 4 700 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 918 | 18 918 | |||||
2013-06-07 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
P - Purchase | 3 600 | 10 991 | 48,71 | 28,61 | 103 010 | 314 495 | |
2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Options (right to buy) |
A - Award | 4 395 | 4 395 | |||||
2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 429 | 7 513 | 6,06 | ||||
2013-03-19 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 13 793 | 13 793 | |||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 17 021 | 17 021 | |||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | -6 340 | 12 700 | -33,30 | ||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | -2 343 | 2 351 | -49,91 | ||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | -2 809 | 7 391 | -27,54 | 35,31 | -99 186 | 260 976 | |
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 8 683 | 10 200 | 572,38 | ||||
2012-11-26 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 123 | 1 517 | 8,82 | ||||
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | -6 666 | 0 | -100,00 | ||||
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | -6 666 | 12 341 | -35,07 | 90,48 | -603 152 | 1 116 636 | |
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 666 | 19 007 | 54,02 | 17,12 | 114 089 | 325 305 | |
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 5 942 | 55 440 | 12,00 | ||||
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 9 547 | 89 072 | 12,01 | ||||
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 6 942 | 64 774 | 12,00 | ||||
2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 3 752 | 3 752 | |||||
2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 369 | 7 084 | 5,50 | ||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | 2 132 | 4 272 | 99,63 | ||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | -738 | 1 394 | -34,62 | 28,74 | -21 210 | 40 064 | |
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 2 132 | 2 132 | |||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 17 328 | 17 328 | |||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 14 177 | 14 177 | |||||
2012-03-13 |
|
4/A | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 6 404 | 6 404 | |||||
2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 49 498 | 49 498 | |||||
2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock |
A - Award | 6 404 | 6 404 |